J 2021

CBD is not converted to THC in rats: A framework interpretation and discussion

VACEK, Jan, Barbora PAPOUSKOVA, Hana HOLCOVÁ POLANSKÁ, Kateřina HÖNIGOVÁ, Jan STORCH et. al.

Basic information

Original name

CBD is not converted to THC in rats: A framework interpretation and discussion

Authors

VACEK, Jan (203 Czech Republic, guarantor), Barbora PAPOUSKOVA (203 Czech Republic), Hana HOLCOVÁ POLANSKÁ (203 Czech Republic, belonging to the institution), Kateřina HÖNIGOVÁ (203 Czech Republic, belonging to the institution), Jan STORCH (203 Czech Republic), Petr BABULA (203 Czech Republic, belonging to the institution) and Michal MASAŘÍK (203 Czech Republic, belonging to the institution)

Edition

European Neuropsychopharmacology, Amsterdam, Elsevier, 2021, 0924-977X

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30104 Pharmacology and pharmacy

Country of publisher

Netherlands

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 5.415

RIV identification code

RIV/00216224:14110/21:00123918

Organization unit

Faculty of Medicine

UT WoS

000688393100016

Keywords in English

CBD; THC; rats

Tags

Tags

International impact, Reviewed
Změněno: 2/5/2022 14:19, Mgr. Tereza Miškechová

Abstract

V originále

Cannabidiol (CBD) is a non-psychotropic exogenous cannabinoid that is an active component in a number of topical and oral preparations. The pharmacological potential of CBD is determined by its anti-inflammatory and immuno- or neuromodulatory activities. This natural terpenoid is widely used today, and therefore more attention is now paid to examining its safety after the administration of high doses (Epidiolex) and also after low-dose chronic exposure, e.g. in the form of food supplements. CBD is therefore a molecule that has recently gained a great deal of scientific interest, both at the level of basic research and industrial development.